# Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank

> **NCT06629363** · — · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier de PAU** · enrollment: 1000 (estimated)

## Conditions studied

- Malignant Hypertension

## Interventions

- **OTHER:** biobank

## Key facts

- **NCT ID:** NCT06629363
- **Lead sponsor:** Centre Hospitalier de PAU
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2036-04-01
- **Final completion:** 2036-04-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629363, "Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06629363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*